Vaginal maturation index self-sample collection in mid-life women: Acceptability and correlation with physician-collected samples

Menopause

Volumn 15, Issue 4, 2008, Pages 726-729

  Hess, Rachel ^a,b,c   Austin, R Marshall ^a   Dillon, Stacey ^a   Chang, Chung Chou Ho ^a,b   Ness, Roberta B ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c University of Pittsburgh ^*  (United States)

Author keywords

Menopause; Sample self collection; Vaginal maturation index

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL ASSESSMENT TOOL; CLINICAL EVALUATION; CORRELATION COEFFICIENT; CRONBACH ALPHA COEFFICIENT; DATA COLLECTION METHOD; EPITHELIUM CELL; FEMALE; FISHER EXACT TEST; HORMONE RESPONSE; HUMAN; MENOPAUSE; STATISTICAL SIGNIFICANCE; VAGINAL MATURATION INDEX; CYTOLOGY; LABORATORY DIAGNOSIS; MIDDLE AGED; SELF CARE; VAGINA; VAGINA SMEAR;

ADULT; AGED; EPITHELIAL CELLS; FEMALE; HUMANS; MENOPAUSE; MIDDLE AGED; SELF CARE; SPECIMEN HANDLING; VAGINA; VAGINAL SMEARS;

EID: 51449083997     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/gme.0b013e31816c5541     Document Type: Article

References (14)

1. McEndree B. Clinical application of the vaginal maturation index. Nurse Pract 1999;24(48):51-52, 55-56.
2. Utian WH, Shoupe D, Bachmann G, Pinkerton JV, Pickar JH. Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate. Fertil Steril 2001;75:1065-1079.
3. Willhite LA, O'Connell MB. Urogenital atrophy: prevention and treatment. Pharmacotherapy 2001;21:464-480.
4. Schneider V. Hormonal cytology: when and why. Diagn Cytopathol 1995;13:163-165.
5. Greendale GA, Zibecchi L, Petersen L, Ouslander JG, Kahn B, Ganz PA. Development and validation of a physical examination scale to assess vaginal atrophy and inflammation. Climacteric 1999;2:197-204.
6. Marx P, Schade G, Wilbourn S, Blank S, Moyer DL, Nett R. Low-dose (0.3 mg) synthetic conjugated estrogens A is effective for managing atrophic vaginitis. Maturitas 2004;47:47-54.
7. Johnson SR, Ettinger B, Macer JL, Ensrud KE, Quan J, Grady D. Uterine and vaginal effects of unopposed ultralow-dose transdermal estradiol. Obstet Gynecol 2005;105:779-787.
8. Simon JA, Bouchard C, Waldbaum A, Utian W, Zborowski J, Snabes MC. Low dose of transdermal estradiol gel for treatment of symptomatic postmenopausal women: a randomized controlled trial. Obstet Gynecol 2007;109:588-596.
9. Schachter J, Chernesky MA, Willis DE, et al. Vaginal swabs are the specimens of choice when screening for Chlamydia trachomatis and Neisseria gonorrhoeae: results from a multicenter evaluation of the APTIMA assays for both infections. Sex Transm Dis 2005;32:725-728.
10. Dzuba IG, Diaz EY, Allen B, et al. The acceptability of self-collected samples for HPV testing vs. the Pap test as alternatives in cervical cancer screening. J Womens Health Gend Based Med 2002;11:265-275.
11. Cook RL, Hutchison SL, Ostergaard L, Braithwaite RS, Ness RB. Systematic review: noninvasive testing for Chlamydia trachomatis and Neisseria gonorrhoeae. Ann Intern Med 2005;142:914-925.
12. Wiesenfeld HC, Lowry DL, Heine RP, et al. Self-collection of vaginal swabs for the detection of chlamydia, gonorrhea, and trichomoniasis: opportunity to encourage sexually transmitted disease testing among adolescents. Sex Transm Dis 2001;28:321-325.
13. Chernesky MA, Hook EW 3rd, Martin DH, et al. Women find it easy and prefer to collect their own vaginal swabs to diagnose Chlamydia trachomatis or Neisseria gonorrhoeae infections. Sex Transm Dis 2005;32:729-733.
14. Ness RB, Kip KE, Soper DE, et al. Bacterial vaginosis (BV) and the risk of incident gonococcal or chlamydial genital infection in a predominantly black population. Sex Transm Dis 2005;32:413-417.